Literature DB >> 34256037

The nephric mesenchyme lineage of intermediate mesoderm is derived from Tbx6-expressing derivatives of neuro-mesodermal progenitors via BMP-dependent Osr1 function.

Shinichi Hayashi1, Hitomi Suzuki1, Tatsuya Takemoto2.   

Abstract

In vertebrate embryos, the kidney primordium metanephros is formed from two distinct cell lineages, Wolffian duct and metanephric mesenchyme, which were classically grouped as intermediate mesoderm. Whereas the reciprocal interactions between these two cell populations in kidney development have been studied extensively, the mechanisms generating them remain elusive. Here, we show that the mouse cell lineage that forms nephric mesenchyme develops as a subpopulation of Tbx6-expressing mesodermal precursor derivatives of neuro-mesodermal progenitors (NMPs) under the condition of bone morphogenetic protein (BMP)-signal-dependent Osr1 expression. The Osr1-expressing nephric mesenchyme precursors were confirmed as descendants of NMPs because they were labeled by Sox2 N1 enhancer-EGFP. In Tbx6 mutant embryos, nephric mesenchyme changed its fate into neural tissues, which reflected its NMP origin. In Osr1 mutant embryos, the specific region of the Tbx6-expressing mesoderm precursor, which normally expresses Osr1 and develops into the nephric mesenchyme, instead expressed the somite marker FoxC2. BMP signaling activated Osr1 expression in a region of TBX6-expressing mesoderm and elicited nephric mesenchyme development. This study suggested a new model of cell lineage segregation during gastrulation.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  Gastrulation; Nephric mesenchyme; Neuro-mesodermal progenitors

Year:  2021        PMID: 34256037     DOI: 10.1016/j.ydbio.2021.07.006

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  1 in total

Review 1.  Mesoderm induction and patterning: Insights from neuromesodermal progenitors.

Authors:  Benjamin L Martin
Journal:  Semin Cell Dev Biol       Date:  2021-11-25       Impact factor: 7.499

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.